Molecular analysis and clinical diversity of distal hereditary motor neuropathy
- 16 April 2020
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 27 (7), 1319-1326
- https://doi.org/10.1111/ene.14260
Abstract
Background Distal hereditary motor neuropathies(dHMN) are a clinically and genetically heterogeneous group of disorders. The purpose of this study was to identify the genetic distribution of dHMN in a large cohort of Chinese patients and provide insight into the underlying common pathophysiology of dHMN. Methods Multi‐gene panel testing or whole‐exome sequencing was performed in 70 index patients with clinically diagnosed dHMN between January 2007 and December 2018. We recorded the clinical features, CMT neuropathy scores (CMTNS) and electrophysiological data at diagnosis. Results We identified 24 causative mutations in 70 index patients with dHMN (34.3%). Mutation in the HSPB1 gene was the most common cause of dHMN. Some CMT genes (MPZ, SH3TC2, GDAP1) were found to be related to dHMN with minor sensory involvement. Patients with a dHMN‐plus phenotype (distal motor neuropathy and additional neurological deficits) carried variants in genes related to hereditary spastic paraplegia, amyotrophic lateral sclerosis and spinal muscular atrophy (FUS, KIF5A, KIF1B, ZFYVE26, DNAJB2). Conclusions Comprehensive genetic testing of dHMN patients allows for identification of the pathogenic mutation in one third of cases. Pure motor neuropathies and motor neuropathies with minor sensory involvement share many genes with CMT. Causes for dHMN‐plus phenotypes overlap with motor neuron disease.Keywords
Funding Information
- National Natural Science Foundation of China (81030019, 81873784)
This publication has 37 references indexed in Scilit:
- Expanding the spectrum of genes responsible for hereditary motor neuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2019
- Phenotype-Driven Virtual Panel Is an Effective Method to Analyze WES Data of Neurological DiseaseFrontiers in Pharmacology, 2019
- Genetic heterogeneity of motor neuropathiesNeurology, 2017
- IGHMBP2 -related clinical and genetic features in a cohort of Chinese Charcot–Marie–Tooth disease type 2 patientsNeuromuscular Disorders, 2016
- MutationTaster2: mutation prediction for the deep-sequencing ageNature Methods, 2014
- Clinical implications of genetic advances in Charcot–Marie–Tooth diseaseNature Reviews Neurology, 2013
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2Current Protocols in Human Genetics, 2013
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)Annals of Neurology, 2003